Home › NDC Lookup › RxCUI directory › RxCUI 313447

Tranylcypromine 10 MG Oral Tablet — RxCUI 313447

RxNorm drug concept · Semantic clinical drug
RxCUI 313447 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313447
Official nameTranylcypromine 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astranylcypromine (as tranylcypromine sulfate) 10 MG Oral Tablet; tranylcypromine sulfate 10 MG Oral Tablet
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)786 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tranylcypromine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tranylcypromine is specifically designed for situations where other antidepressants haven't worked well enough. It works through a completely different mechanism than SSRIs or SNRI...
  • Why has my doctor prescribed tranylcypromine when I've already tried other antidepressants?
  • This is one of the most important things to get right. You need to avoid foods and drinks high in tyramine — including aged cheeses, cured or air-dried meats like salami, pickled h...
  • What foods do I absolutely need to avoid while taking this medication?
📖 Read our full Tranylcypromine guide →

🕸️ Concept Web — How Tranylcypromine 10 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tranylcypromine 10 MG Oral Tablet RxCUI 313447

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tranylcypromine 10734
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Parnate 203832
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tranylcypromine Oral Tablet 374182
    • Tranylcypromine Oral Product 1157672
    • Tranylcypromine Pill 1157673
    • Tranylcypromine Oral Tablet [Parnate] 369259
    • Parnate Oral Product 1182387
    • Parnate Pill 1182388
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tranylcypromine 10 MG SCDC · 328687
  • Tranylcypromine Oral Tablet SCDF · 374182
  • Tranylcypromine Oral Product SCDG · 1157672
  • Tranylcypromine Pill SCDG · 1157673

Brand-Name Concepts

  • Tranylcypromine 10 MG Oral Tablet [Parnate] SBD · 104838
  • Tranylcypromine 10 MG [Parnate] SBDC · 563780
  • Tranylcypromine Oral Tablet [Parnate] SBDF · 369259
  • Parnate Oral Product SBDG · 1182387
  • Parnate Pill SBDG · 1182388
  • Parnate BN · 203832

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 313447 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-5590-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-5590-01) Tranylcypromine Sulfate Actavis Pharma, Inc. 2016-02-05
43547-0655-10 100 TABLET in 1 BOTTLE (43547-655-10) Tranylcypromine Solco Healthcare US, LLC 2022-12-10
59212-0447-10 100 TABLET, FILM COATED in 1 BOTTLE (59212-447-10) PARNATE Advanz Pharma (US) Corp. 2013-01-14
64380-0176-01 100 TABLET, FILM COATED in 1 BOTTLE (64380-176-01) TRANYLCYPROMINE SULFATE Strides Pharma Science Limited 2022-04-11
70954-0538-10 100 TABLET in 1 BOTTLE (70954-538-10) Tranylcypromine Novitium Pharma LLC 2021-06-06
Observed labelers: Actavis Pharma, Inc. (1) · Advanz Pharma (US) Corp. (1) · Novitium Pharma LLC (1) · Solco Healthcare US, LLC (1) · Strides Pharma Science Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.